CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2022	Sep. 30, 2021
Current assets:
Cash and cash equivalents	$ 28,073,673	$ 36,060,148
U.S. Treasury Bills	0	6,151,385
Receivables	0	54,922
Prepaid expenses	708,621	998,482
Supplies used for R&D and manufacturing	2,173,037	2,006,584
Total current assets	30,955,331	45,271,521
Finance lease right of use assets	11,389,249	12,691,921
Operating lease right of use assets	1,928,561	2,056,178
Property and equipment, net	12,394,189	13,663,562
Patent costs, net	222,462	275,866
Deposits	0	1,910,917
Total assets	56,889,792	75,869,965
Current liabilities:
Accounts payable	852,860	1,675,813
Accrued expenses	992,945	859,216
Due to employees	496,005	265,993
Derivative instruments, current portion	0	437,380
Lease liabilities, current portion	1,673,653	698,665
Total current liabilities	4,015,463	3,937,067
Finance lease obligations, net of current portion	12,124,979	13,252,364
Operating lease obligations, net of current portion	1,895,987	2,021,308
Other liabilities	125,000	125,000
Total liabilities	18,161,429	19,335,739
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value - 200,000 shares authorized; 0 shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 43,355,529 and 43,207,183 shares issued and outstanding at June 30, 2022 and September 30, 2021, respectively	433,555	432,072
Additional paid-in capital	484,729,902	474,298,566
Accumulated deficit	(446,435,094)	(418,196,412)
Total stockholders' equity	38,728,363	56,534,226
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 56,889,792	$ 75,869,965